Early Insights into COVID-19 in Persons Living with HIV and Cardiovascular Manifestations
Jelani K Grant1, Louis Vincent1, Bertrand Ebner1
1Department of Medicine, University of Miami Miller School of Medicine/Jackson Memorial Hospital, Miami, Florida, USA.
Insights
People with HIV-1 (PLHIV) face higher cardiovascular risks. This review examines if COVID-19 worsens cardiovascular issues in PLHIV, considering the combined inflammatory effects.
Area of Science:
- Infectious Diseases
- Cardiology
- Immunology
Background:
- Persons living with HIV-1 (PLHIV) have a persistent inflammatory state increasing cardiovascular complication risk, even with viral suppression.
- SARS-CoV-2 (COVID-19) infection causes acute cardiovascular complications due to its associated inflammatory response.
- The impact of COVID-19 on cardiovascular health in PLHIV is not yet fully understood.
Purpose of the Study:
- To review and consider the potential for exacerbated cardiovascular manifestations in individuals coinfected with HIV-1 and COVID-19.
Main Methods:
- This study is a review of existing literature and research.
- Analysis of the combined effects of HIV-1 and SARS-CoV-2 on cardiovascular health.
- Consideration of inflammatory pathways in coinfection.
Main Results:
- HIV-1 infection is associated with increased cardiovascular risk due to chronic inflammation.
- COVID-19 triggers acute cardiovascular complications via inflammation.
- The synergistic effect of coinfection on cardiovascular outcomes requires further investigation.
Conclusions:
- Coinfection with HIV-1 and COVID-19 may lead to more severe cardiovascular complications.
- Understanding these combined effects is crucial for managing coinfected individuals.
- Further research is needed to elucidate the specific risks and mechanisms involved.
Abstract:
Persons living with HIV-1 (PLHIV) are at increased risk of cardiovascular complications in part due to the persistent inflammatory state despite viral suppression. SARS-CoV-2, the virus causing COVID-19, was declared a pandemic virus in March 2020, and caused over 30 million cases and 900,000 deaths worldwide to date. Individuals with COVID-19 are manifesting acute cardiovascular complications because of the inflammatory response associated with SARS-CoV-2 infection. It is not yet known whether having COVID-19 in the context of ongoing HIV-1 infection results in worse cardiovascular complications than in PLHIV who have not had COVID-19 infection. In this review, the potential for exacerbated cardiovascular manifestations in persons coinfected with HIV-1 and COVID-19 is considered.
More Related Videos
07:15Single-Cell Characterization of Calcium Influx and HIV-1 Infection using a Multiparameter Optofluidic Platform
Published on: May 18, 2021
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Sexually Transmitted Infections
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
